About the Company

DUSA Pharmaceuticals, Inc.® is an integrated dermatology specialty pharmaceutical company focused primarily on the development and marketing of its Levulan® Photodynamic Therapy (PDT) technology platform, and complementary dermatology products. Levulan® PDT is currently approved for the treatment of Grade 1 and 2 actinic keratoses of the face or scalp, and is being developed for the treatment of acne. DUSA's other dermatology products include ClindaReach^TM and Nicomide®. DUSA is also supporting development of certain internal indications of Levulan® PDT. DUSA is based in Wilmington, MA.

WEB 1385 Rev C